Flu activity in the United States is finally slowing down, but health experts say this year’s flu vaccine didn't offer as ...

The good news: As the weather is turning warmer, flu season is officially headed off a cliff. The bad news: The efficacy of ...

WHO announces updated influenza vaccine strains for the 2026–27 northern hemisphere season, reflecting evolving flu virus ...

As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well, with one of its worst ...

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised application seeking full approval of the shot for adults ages 50 to 64, and ...

Vaccine effectiveness was 38 to 41 percent against influenza outpatient visits, 41 percent against flu-linked hospitalization ...

The US FDA’s vaccine advisors have recommended that three new influenza strains be included in next winter’s influenza vaccine, aiming in part to tamp down illness caused by subclade K, a mutated form ...

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.

Although the Centers for Disease Control and Prevention (CDC) classifies the current flu season as “moderate,” at least 90 ...

More than 100 children have died so far this season ...

A judge suspended the CDC’s vaccine advisory committee, but also said the agency should be consulting it before making ...